Australia – TGA Creates Guidance on Difference Between Disease Education and Drug Promotion

TGA has published guidance for providers of disease education activities. The guidance is intended to help such organizations to continue raising awareness of diseases without violating TGA restrictions on the promotion of therapeutic goods.

Disease awareness was a source of disagreement between TGA and the industry when the agency set out its planned changes to the advertising code late in 2017. Trade group Medicines Australia warned TGA’s planned ban on naming a “specific therapeutic good or sponsor either expressly or by implication” in disease awareness campaigns risked disrupting educational initiatives and reducing transparency.

TGA revised its position in response to industry feedback but remains concerned about the potential for disease awareness campaigns to promote therapeutic goods, either deliberately or inadvertently. In light of those concerns, TGA set out its position on a guidance document…